- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05804812
The Effect of Laughter Therapy in Women
July 5, 2023 updated by: Sinop University
The Effect of Laughter Therapy in Women With Migraine
Migraine: An episodic disorder consisting of severe headache, usually with photophobia (sensitivity to light), phonophobia (sensitivity to sound), and/or nausea (occasionally vomiting).
Migraine is predominantly a female disease.
The incidence of migraine was found to in women (18.2/1000 person-years) and between the ages of 15-19 in men (6.2/1000 person-years).
The incidence of migraine was found to peak between the ages of 20-24 in women (18.2/1000 person-years) and between the ages of 15-19 in men (6.2/1000 person-years).
Migraine treatments are generally classified as pharmacological (treatment with medication) and non-pharmacological (treatment with no medication).
Laughter therapy has recently come to the fore as a non-pharmacological and alternative treatment in chronic pain management.
In a randomized controlled study, 30 minutes of laughter therapy was applied to women on the 2nd and 6th days after mastectomy surgery and it was determined that women who received laughter therapy had a significant decrease in pain and anxiety levels.
This study was planned to determine the effect of laughter therapy on women with migraine.
Study Overview
Detailed Description
The research will be carried out with young girls who are studying at the Faculty of Health Sciences of Sinop University in the 2022-2023 academic spring semester.
Inclusion criteria for the research: Faculty of Health Sciences, to study in the 2022-2023 academic spring semester, to have been diagnosed with migraine, to be young girls and to volunteer to participate in the research.
Exclusion criteria from the study; Not studying at the Faculty of Health Sciences and not volunteering to participate in the research.
The application and control group will be determined on random.org
among the group that constitutes the sample of the study.
Laughter therapy sessions will be applied online for 25-30 minutes once a week for 2 months by the researcher who has the Laughter therapy certificate to the application group.
At the end of two months, the Personal Information Form and Psychological Well-Being Scale will be administered again to both the application group and the control group.
Study Type
Interventional
Enrollment (Actual)
53
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Sinop, Turkey, 57000
- Sınop Univercity
-
Sinop, Turkey, 57000
- Sinop üniversitesi
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 24 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Being a nursing student,
- Being a female student,
- Volunteering to participate in the study.
- Being a woman
- Being diagnosed with migraine
Exclusion Criteria:
Not to study as a nursing student
- Being a male student
- Not to volunteer to participate in the study
- Not being a woman between the ages of 18 and 30
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: control group
At the beginning of the study, data collection tools Personal Information Form and Psychological Well-Being Scale will be applied to the control group. No intervention will be made in the control group. Measurement tools will be applied for the post-test. |
|
|
Experimental: experimental group
Inclusion criteria for the research: Faculty of Health Sciences, to study in the 2022-2023 academic spring semester, to have been diagnosed with migraine, to be young and to volunteer to participate in the research.
Exclusion criteria from the study; Not studying at the Faculty of Health Sciences and not volunteering to participate in the research.
The application and control group will be determined on random.org
among the group that constitutes the sample of the study.
Laughter therapy sessions will be applied online for 25-30 minutes once a week for 2 months by the researcher who has the Laughter therapy certificate to the application group.
At the end of two months, the Personal Information Form and Psychological Well-Being Scale will be administered again to both the application group and the control group.
|
Assigned Interventions Laughter therapy session will be applied online for 25-30 minutes once a week for 2 months by the researcher who has the Laughter therapy certificate to the application group.
In the laughter therapy session, the practices of introducing the practitioner and introducing the therapy, breathing exercises for a healthy life, keeping the rhythm accompanied by music, turning the laughter that started as if it were childlike games into reality will be carried out.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
1. Personal İnformation form
Time Frame: one day
|
Personal İnformation form consists of 2 parts.
In the first part, the socio-demographic characteristics of the individual, such as class, age, place and region where he lives the longest, mother and father working status, economic status, consist of 9 questions.
In the second part, it consists of a total of 9 questions about the characteristics of migraine, including migraine location, frequency, duration of attendance, duration of medication, severity, coping methods, complaints associated with migraine, time without medication, and school attendance.
|
one day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
2. Psychological Well-Being Scale:
Time Frame: one day
|
The Psychological Well-Being Scale was developed by Diener et al. (2009-2010) to measure socio-psychological well-being, complementary to existing well-being measures.
The Turkish adaptation of the scale was done by Telef (2011; 2013).
It was determined that the item-total correlations of the Psychological Well-Being Scale varied between .41 and .63,
and the t-values were significant (p<.001).
The items of the Psychological Well-Being Scale are answered between 1 and 7, as I strongly disagree (1) to I strongly agree (7).
All items are expressed positively.
Scores range from 8 (strongly disagree to all items) to 56 (strongly agree to all items).
|
one day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Meryem Erdoğan, PhD, Sinop University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 6, 2023
Primary Completion (Actual)
May 25, 2023
Study Completion (Actual)
June 28, 2023
Study Registration Dates
First Submitted
March 27, 2023
First Submitted That Met QC Criteria
March 27, 2023
First Posted (Actual)
April 7, 2023
Study Record Updates
Last Update Posted (Actual)
July 7, 2023
Last Update Submitted That Met QC Criteria
July 5, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- sinopUmeryem-2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Migraine
-
Hospital Universitari Vall d'Hebron Research InstituteRecruitingMigraine | Migraine Headache | Migraine Without Aura | Migraine with Aura | Chronic Migraine, Headache | Episodic Migraine | Chronic Migraine Headache | Headache (Migraine) | Episodic Migraine HeadacheSpain
-
Brigham and Women's HospitalNot yet recruitingMigraine Disorders | Migraine Without Aura | Migraine With Aura | Episodic MigraineUnited States
-
Miracle Wellness LLCNot yet recruitingMigraine | Migraine Headache | Menstrual Migraine | Menstrual Migraine (MM) Headaches | Migraine Disorder | Migraine in Adults | Migraine Disease | Migraine DisabilityUnited States
-
Austrian Migraine Registry CollaborationMedical University of Vienna; Medical University Innsbruck; Austrian Headache...RecruitingMigraine | Chronic Migraine | Migraine Without Aura | Migraine With Aura | Episodic MigraineAustria
-
Hinge Health, IncRecruitingMigraine | Migraine Without Aura | Migraine With AuraUnited States
-
CoolTech LLCTerminatedMigraine | Migraine Without Aura | Migraine With Aura | Episodic MigraineUnited States
-
Harvard University Faculty of MedicineBrigham and Women's Hospital; Palmer Center for Chiropractic Research (PCCR)CompletedMigraine | Migraine Disorders | Migraine Without Aura | Migraine With Aura | Migraine, ClassicUnited States
-
Tonix Pharmaceuticals, Inc.PremierCompletedChronic Migraine | Chronic Migraine, Headache | Chronic Migraine Without Aura | Aura MigraineUnited States
-
University of AlbertaCanadian Institutes of Health Research (CIHR)CompletedMigraine Without Aura | Migraine With Aura | Probable MigraineCanada
-
Ariston Pharmaceuticals, Inc.UnknownMigraine | Migraine Disorders | Migraine Headache | Migraine Without Aura | Migraine With AuraFinland, Netherlands, United Kingdom
Clinical Trials on laughter therapy
-
Zonguldak Bulent Ecevit UniversityNot yet recruitingQuality of Life | Burnout, Professional | Stress, Psychological | Compassion Fatigue | Decision Making | Problem Solving | Work Performance
-
Artvin Coruh UniversityAtaturk UniversityRecruiting
-
Mersin UniversityCompletedSleep | Vasomotor; SyndromeTurkey
-
Mersin UniversityNot yet recruitingQuality of Life | Premenstrual Syndrome
-
Saglik Bilimleri UniversitesiCompletedPre-operative AnxietyTurkey (Türkiye)
-
Sinop UniversityNot yet recruitingQuality of Life | Laughter
-
Selcuk UniversityEnrolling by invitationLactation | Postnatal CareTurkey
-
Sinop UniversityCompleted
-
Istanbul University - Cerrahpasa (IUC)CompletedStoma Ileostomy | Stoma ColostomyTurkey
-
Celal Bayar UniversityCompletedHealthy | Stress | LaughterTurkey